When and how to identify resistance mechanisms to targeted therapies

Nicolas Girard (France)

Source: New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine
Number: 6

Slide presentationWebcast

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Nicolas Girard (France). When and how to identify resistance mechanisms to targeted therapies. New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: